1,200 m2 of newly built cleanrooms at Byondis (formerly Synthon)

Byondis Nijmegen, mAb Plant

Detail engineering and installation of a Monoclonal Antibody (mAb) Plant, in collaboration with Heijmans.
In the mAb plant, therapeutic protein molecules are produced for use in cancer drugs.